Skip to main content

Table 5 The strains used in seasonal influenza vaccines from 2001 to 2015 and amino acid residue(s) of potential N-linked glycosylation sites on the globular head of HA in these strains

From: Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic

Year

Northern hemisphere

Amino acid residue(s)

Southern hemisphere

Amino acid residue(s)

144

144-146

144

144-146

2014–15

A/Texas/50/2012 (H3N2)

N

NNS

A/Switzerland/9715293/2013 (H3N2)

N

NSS

2013–14

A/Victoria/361/2011(H3N2)

N

NNS

A/Texas/50/2012 (H3N2)

N

NNS

2012–13

A/Victoria/361/2011(H3N2)

N

NNS

A/Victoria/361/2011(H3N2)

N

NNS

2011–12

A/Perth/16/2009 (H3N2)

K

KNS

A/Perth/16/2009 (H3N2)

K

KNS

2010–11

A/Perth/16/2009 (H3N2)

K

KNS

A/Perth/16/2009 (H3N2)

K

KNS

2009–10

A/Brisbane/10/2007 (H3N2)

N

NNS

A/Perth/16/2009 (H3N2)

K

KNS

2008–09

A/Brisbane/10/2007 (H3N2)

N

NNS

A/Brisbane/10/2007 (H3N2)

N

NNS

2007–08

A/Wisconsin/67/2005 (H3N2)

N

NNS

A/Brisbane/10/2007 (H3N2)

N

NNS

2006–07

A/Wisconsin/67/2005 (H3N2)

N

NNS

A/Wisconsin/67/2005 (H3N2)

N

NNS

2005–06

A/California/7/2004(H3N2)

N

NNS

A/California/7/2004(H3N2)

N

NNS

2004–05

A/Fujian/411/2002(H3N2)

N

NKS

A/Wellington/1/2004(H3N2)

N

NKS

2003–04

A/Moscow/10/99(H3N2)

I

INS

A/Fujian/411/2002(H3N2)

N

NKS

2002–03

A/Moscow/10/99(H3N2)

I

INS

A/Moscow/10/99(H3N2)

I

INS

2001–02

A/Moscow/10/99(H3N2)

I

INS

A/Moscow/10/99(H3N2)

I

INS